Filters
Hikma Pharmaceuticals Preliminary Results
Press Release, Corporate
Hikma Pharmaceuticals partners with Ergomed for clinical trials of anti-cancer medication
Press Release, Product
Hikma receives approval of its NDA for Argatroban Injection, 100mg/mL vial
Press Release, Product
Hikma launches therapeutic heparin in the US market
Press Release, Product
Hikma in-licenses major proprietary injectable product Ferinject® for the MENA region
Press Release, Product
Hikma Pharmaceuticals Supports PACES Initiative
Press Release, Responsibility
Hikma Holds Global Volunteering Day For The 4th Consecutive Year
Press Release, Responsibility
Hikma Pharmaceuticals Signs Agreement to Develop an Industrial Pharmaceuticals Faculty
Press Release, Responsibility
Samih Darwazah Center for Innovation Management and Entrepreneurship Launched at American University of Beirut
Press Release, Responsibility
Hikma Receives FDA Approval for Cancer Drug Irinotecan
Press Release, Product
Hikma CEO Speaks at Harvard School of Public Health’s MENA Conference
Press Release, Responsibility
Hikma Pharmaceuticals Holds Diabetes Awareness Campaign
Press Release, Responsibility
Hikma Pharmaceuticals Holds Anti-Obesity Campaign
Press Release, Responsibility
Hikma Pharmaceuticals Holds Breast Cancer Awareness Campaign
Press Release, Responsibility